FINGOLIMOD
Generic: FINGOLIMOD
XLCare Pharmaceuticals Inc.Manufacturer
ORALRoute
FINGOLIMOD HYDROCHLORIDEActive Substance
2020-05-18Original Approval
FINGOLIMOD is FDA application ANDA207933, sponsored by HETERO LABS LTD V. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Top Reported Reactions
1
MULTIPLE SCLEROSIS RELAPSE
629 reports
2
LYMPHOPENIA
494 reports
3
MULTIPLE SCLEROSIS
341 reports
4
FATIGUE
311 reports
5
DRUG INEFFECTIVE
279 reports
6
HEADACHE
222 reports
7
LYMPHOCYTE COUNT DECREASED
200 reports
8
COVID-19
174 reports
9
DIZZINESS
168 reports
10
GAIT DISTURBANCE
166 reports